1 / 5

Demand for Non-Small Cell Lung CancerTherapeutics to Reach $50 billion by 2030

This global Non-Small Cell Lung Cancer Therapeutics report analyzes the market based on Cancer Type, Therapy Type, End-User, and by geographic region for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030. The global market for Non-Small Cell Lung Cancer (NSCLC) Therapeutics is estimated at US$27.7 billion in 2024 and is anticipated to record a CAGR of 10.3% during the 2024-2030 analysis period and stand at a projected US$50 billion by 2030.

industryexperts
Download Presentation

Demand for Non-Small Cell Lung CancerTherapeutics to Reach $50 billion by 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Severe Air Pollution and Increasing Consumption of Tobacco Bolster the Demand for Non-Small Cell Lung Cancer (NSCLC) Therapeutics to Reach $50 billion by 2030

  2. A new report from Industry Experts, Inc. on "Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market" is released. According to this global market research report, the global market for Non-Small Cell Lung Cancer (NSCLC) Therapeutics is estimated at US$27.7 billion in 2024 and is anticipated to record a CAGR of 10.3% during the 2024-2030 analysis period and stand at a projected US$50 billion by 2030.

  3. The market for non-small cell lung cancer (NSCLC) therapeutics analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

  4. The study analyzes the global market for non-small cell lung cancer (NSCLC) therapeutics analyzed with respect to Cancer Type – Adenocarcinoma, Squamous cell carcinoma (SCC), Large cell carcinoma and Other Cancers (Including Adenosquamous Carcinoma and Sarcomatoid Carcinoma); Therapy Type – Targeted Therapies, Immunotherapy, Chemotherapy, Radiation Therapy and Others (Including Surgery, Photodynamic Therapy (PDT), and Palliative Care); and End-User – Hospitals, Specialty Clinics and Other End-Users (Including Cancer Research Centers, Ambulatory Surgical Centers (ASCs), and Homecare settings).

  5. About Industry Experts, Inc. Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

More Related